Evidence map›Paper›PMID 16333088›Full record

ArticleJournal of clinical microbiology2005

Mistaken identity: Neosartorya pseudofischeri and its anamorph masquerading as Aspergillus fumigatus.

S Arunmozhi Balajee, Jennifer Gribskov, Mary Brandt, James Ito, Annette Fothergill, Kieren A Marr

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Azole Resistance inJournal of fungi (Basel, Switzerland) · 2025
    Article
  3. Environment & health (Washington, D.C.) · 2025
    Article
  4. First case of fungal peritonitis caused byMedical mycology case reports · 2024
    Article
  5. Review
  6. Soil-BorneInternational journal of molecular sciences · 2023
    Review
  7. Article
  8. Journal of fungi (Basel, Switzerland) · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

S Arunmozhi BalajeeProgram in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., D3-100, Seattle, WA 98109, USA.
Jennifer Gribskov
Mary Brandt
James Ito
Annette Fothergill
Kieren A Marr

Funding

Antifungal Drug Resistance in AspergillusR21AI055928 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MARR, KIEREN A. · 2003 to 2004
$507k
NIAID NIH HHS R21 AI 055928NIAID NIH HHS R21 AI055928
6 · The paper itself

Abstract

Invasive fungal infections caused by Neosartorya pseudofischeri S. W. Peterson [anamorph Aspergillus thermomutatus (Paden) S. W. Peterson] are extremely rare. Phenotypically, the anamorphic state of N. pseudofischeri resembles Aspergillus fumigatus, the predominant agent of invasive aspergillosis in immunocompromised hosts. We report the recovery of three clinical isolates of N. pseudofischeri, all initially misidentified by morphological characteristics as A. fumigatus. All three isolates were correctly identified by sequencing portions of the beta-tubulin and the rodlet A genes. Only one of the three isolates produced the confirmatory fruiting bodies and was thus classified as N. pseudofischeri; the other isolates did not produce asci and were therefore identified as A. thermomutatus. All three isolates had higher MICs to voriconazole in vitro compared to A. fumigatus Af293. This report emphasizes that phenotypic identification of filamentous fungi may not identify morphologically similar, but genetically distinct, members of the genus Aspergillus section Fumigati. Accurate identification of these organisms may be clinically meaningful, given their potential differences in antifungal susceptibilities.

Indexed as

Diagnostic ErrorsAntifungal AgentsAspergillosisAspergillus fumigatusDNA, FungalEndocarditisEurotialesHumansLung Diseases, FungalMicrobial Sensitivity TestsMycological Typing TechniquesMycosesPeritonitisPhenotypeAntifungal AgentsDNA, Fungal

Identifiers

PMID16333088
PMCPMC1317194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.